Ya-Ling HAN, Yu-Ming LI, Chang-Sheng MA. Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19. J Geriatr Cardiol 2020; 17(5): 241-242. doi: 10.11909/j.issn.1671-5411.2020.05.001
Citation:
|
Ya-Ling HAN, Yu-Ming LI, Chang-Sheng MA. Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19. J Geriatr Cardiol 2020; 17(5): 241-242. doi: 10.11909/j.issn.1671-5411.2020.05.001
|
Ya-Ling HAN, Yu-Ming LI, Chang-Sheng MA. Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19. J Geriatr Cardiol 2020; 17(5): 241-242. doi: 10.11909/j.issn.1671-5411.2020.05.001
Citation:
|
Ya-Ling HAN, Yu-Ming LI, Chang-Sheng MA. Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19. J Geriatr Cardiol 2020; 17(5): 241-242. doi: 10.11909/j.issn.1671-5411.2020.05.001
|
Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19
- Received Date: 2020-04-14
- Rev Recd Date:
2020-04-20
- Publish Date:
2020-05-01